Sound View Wealth Advisors Group LLC Has $899,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

Sound View Wealth Advisors Group LLC boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 5.2% in the fourth quarter, HoldingsChannel reports. The firm owned 6,797 shares of the financial services provider’s stock after buying an additional 335 shares during the period. Sound View Wealth Advisors Group LLC’s holdings in iShares Biotechnology ETF were worth $899,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Larson Financial Group LLC grew its stake in shares of iShares Biotechnology ETF by 6.2% in the 4th quarter. Larson Financial Group LLC now owns 1,753 shares of the financial services provider’s stock valued at $232,000 after buying an additional 102 shares during the period. Generali Investments CEE investicni spolecnost a.s. bought a new position in iShares Biotechnology ETF in the fourth quarter worth approximately $11,370,000. Marco Investment Management LLC grew its stake in iShares Biotechnology ETF by 16.7% in the fourth quarter. Marco Investment Management LLC now owns 4,886 shares of the financial services provider’s stock valued at $646,000 after acquiring an additional 700 shares during the period. Bay Colony Advisory Group Inc d b a Bay Colony Advisors increased its holdings in shares of iShares Biotechnology ETF by 16.2% during the fourth quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors now owns 2,309 shares of the financial services provider’s stock valued at $305,000 after acquiring an additional 322 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC raised its position in shares of iShares Biotechnology ETF by 344.2% during the fourth quarter. Ashton Thomas Private Wealth LLC now owns 23,502 shares of the financial services provider’s stock worth $3,107,000 after purchasing an additional 18,211 shares during the period. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 0.5 %

Shares of IBB opened at $136.95 on Monday. The stock has a market cap of $6.47 billion, a P/E ratio of 24.52 and a beta of 0.84. The business’s fifty day moving average is $136.08 and its 200 day moving average is $140.22. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.